Skip to main content
Grant Details

Grant Number: 5U24CA078134-05 Interpret this number
Primary Investigator: Anton-Culver, Hoda
Organization: University Of California Irvine
Project Title: Uci Ucsd Cancer Genetics Network
Fiscal Year: 2002


DESCRIPTION: (Applicant's Description) Newly emerging technology for mutation detection and high-throughput sequencing of genes will make obsolete many of the previous and some of the current research strategies in the genetic epidemiology of cancer. The proposed UCI-UCSD Cancer Genetics Network (UCI-UCSD CGN) will be accomplished through the existing strengths of its co-investigators, community clinicians, existing resources, and previous experience in genetic epidemiology of cancer. Fundamental to the new NCI direction is the participation of clinicians, the community they serve, and basic scientists and epidemiologists. Also integral to the strategy is the dissemination of the growing body of genetic information to all participants and the provision of genetic counseling to those affected by the discovery of cancer mutations. The UCI-UCSD CGN will serve as an infrastructure for collaborative research investigations into the genetic basis of human cancer susceptibility. 1) The infrastructure will include basic network activities. These activities include the recruitment and follow-up of Network Participants, the collection and storage of core information, the maintenance of a local informatics system, a core laboratory for the processing and storage of biological specimens for specific projects, and the maintenance of informatics and communications technology to interface with the Nationwide Network. The UCI-- UCSD CGN will recruit potential enrollees from a total population of approximately 264,450 individuals. This population will include individuals at high-risk for cancer due to family history, members of the VA Desert Pacific Health Care Network, cancer patients including those with multiple primary cancer from the Cancer Surveillance Program of Orange, San Diego, and Imperial Counties, referrals from community clinics, physicians, and hospitals, and cancer survivors who are members of advocacy and community groups. Once enrolled, network members will complete a one-page interview of basic family history and risk factor information and will be followed annually. Genetic counseling and education will be made available to network members and referral physicians. 2) UCI-UCSD CGN will expand research capabilities to support Network activities, specifically in areas of molecular genetics, clinical genetics, genetic counseling, and education. A network of top quality principal investigators and co-investigators will provide an infrastructure for joint research efforts between scientists and clinicians. The UCI-UCSD CGN will sponsor scientific seminars and conferences that will facilitate the translation of molecular genetics research into clinical practice. The majority of the elements of the proposed network have already been established by our group and communications among them are in place.


Early Detection of Ovarian Cancer using the Risk of Ovarian Cancer Algorithm with Frequent CA125 Testing in Women at Increased Familial Risk - Combined Results from Two Screening Trials.
Authors: Skates S.J. , Greene M.H. , Buys S.S. , Mai P.L. , Brown P. , Piedmonte M. , Rodriguez G. , Schorge J.O. , Sherman M. , Daly M.B. , et al. .
Source: Clinical cancer research : an official journal of the American Association for Cancer Research, 2017-07-15; 23(14), p. 3628-3637.
EPub date: 2017-01-31.
PMID: 28143870
Related Citations

Long-term risk of medical conditions associated with breast cancer treatment.
Authors: Hill D.A. , Horick N.K. , Isaacs C. , Domchek S.M. , Tomlinson G.E. , Lowery J.T. , Kinney A.Y. , Berg J.S. , Edwards K.L. , Moorman P.G. , et al. .
Source: Breast cancer research and treatment, 2014 May; 145(1), p. 233-43.
EPub date: 2014-04-03.
PMID: 24696430
Related Citations

Meat consumption, ornithine decarboxylase gene polymorphism, and outcomes after colorectal cancer diagnosis.
Authors: Zell J.A. , Lin B.S. , Ziogas A. , Anton-Culver H. .
Source: Journal of carcinogenesis, 2012; 11, p. 17.
EPub date: 2012-11-28.
PMID: 23233821
Related Citations

Activating mutation in MET oncogene in familial colorectal cancer.
Authors: Neklason D.W. , Done M.W. , Sargent N.R. , Schwartz A.G. , Anton-Culver H. , Griffin C.A. , Ahnen D.J. , Schildkraut J.M. , Tomlinson G.E. , Strong L.C. , et al. .
Source: BMC cancer, 2011-10-04; 11, p. 424.
EPub date: 2011-10-04.
PMID: 21970370
Related Citations

Large prospective study of ovarian cancer screening in high-risk women: CA125 cut-point defined by menopausal status.
Authors: Skates S.J. , Mai P. , Horick N.K. , Piedmonte M. , Drescher C.W. , Isaacs C. , Armstrong D.K. , Buys S.S. , Rodriguez G.C. , Horowitz I.R. , et al. .
Source: Cancer prevention research (Philadelphia, Pa.), 2011 Sep; 4(9), p. 1401-8.
PMID: 21893500
Related Citations

Clinically relevant changes in family history of cancer over time.
Authors: Ziogas A. , Horick N.K. , Kinney A.Y. , Lowery J.T. , Domchek S.M. , Isaacs C. , Griffin C.A. , Moorman P.G. , Edwards K.L. , Hill D.A. , et al. .
Source: JAMA, 2011-07-13; 306(2), p. 172-8.
PMID: 21750294
Related Citations

Associations of a polymorphism in the ornithine decarboxylase gene with colorectal cancer survival.
Authors: Zell J.A. , Ziogas A. , Ignatenko N. , Honda J. , Qu N. , Bobbs A.S. , Neuhausen S.L. , Gerner E.W. , Anton-Culver H. .
Source: Clinical cancer research : an official journal of the American Association for Cancer Research, 2009-10-01; 15(19), p. 6208-16.
EPub date: 2009-09-29.
PMID: 19789310
Related Citations

Common familial colorectal cancer linked to chromosome 7q31: a genome-wide analysis.
Authors: Neklason D.W. , Kerber R.A. , Nilson D.B. , Anton-Culver H. , Schwartz A.G. , Griffin C.A. , Lowery J.T. , Schildkraut J.M. , Evans J.P. , Tomlinson G.E. , et al. .
Source: Cancer research, 2008-11-01; 68(21), p. 8993-7.
PMID: 18974144
Related Citations

BRAF polymorphisms and the risk of ovarian cancer of low malignant potential.
Authors: Kelemen L. , James M. , Spurdle A. , Campbell I. , Chang-Claude J. , Peel D. , Anton-Culver H. , Berchuck A. , Schildkraut J. , Whittemore A. , et al. .
Source: Gynecologic oncology, 2005 Jun; 97(3), p. 807-12.
PMID: 15904951
Related Citations

Validation of family history data in cancer family registries.
Authors: Ziogas A. , Anton-Culver H. .
Source: American journal of preventive medicine, 2003 Feb; 24(2), p. 190-8.
PMID: 12568826
Related Citations

Back to Top